Acquired
Novo Nordisk (Ozempic)
David Rosenthal
So I think it's worth a quick pause here. We've already talked about some of this, but just to clarify why diabetes and insulin is such an interesting market and large market potential. You know, one, even with just type 1 at this point in time, it's still a very large and widespread disease in the world. So it's kind of a large patient and potential patient market size.
0
💬
0
Comments
Log in to comment.
There are no comments yet.